Controversies in regenerative medicine: Should intervertebral disc degeneration be treated with mesenchymal stem cells?
Low back pain (LBP) can significantly reduce the quality of life of patients, and has a considerable economic and social impact worldwide. It is commonly associated with disc degeneration, even though many people with degenerate discs are asymptomatic. Degenerate disc disease (DDD), is thus a common...
Main Authors: | Markus Loibl, Karin Wuertz‐Kozak, Gianluca Vadala, Siegmund Lang, Jeremy Fairbank, Jill P. Urban |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | JOR Spine |
Subjects: | |
Online Access: | https://doi.org/10.1002/jsp2.1043 |
Similar Items
-
Application of stem cells in the repair of intervertebral disc degeneration
by: Wentao Zhang, et al.
Published: (2022-02-01) -
Role of Autophagy and Pyroptosis in Intervertebral Disc Degeneration
by: Wang Z, et al.
Published: (2024-01-01) -
Umbilical cord mesenchymal stem cells for regenerative treatment of intervertebral disc degeneration
by: Huagui Huang, et al.
Published: (2023-08-01) -
Mesenchymal stem cell therapies for intervertebral disc degeneration: Consideration of the degenerate niche
by: Louise Vickers, et al.
Published: (2019-06-01) -
Multiscale Regulation of the Intervertebral Disc: Achievements in Experimental, In Silico, and Regenerative Research
by: Laura Baumgartner, et al.
Published: (2021-01-01)